tirzepatide surmount-1 percent weight loss 72 weeks Dose-equivalence reference based on pivotal GLP-1/dual-agonist trials: (tirzepatide/Zepbound, weeks) STEP-1 (subcutaneous semaglutide/Wegovy, 68 weeks) OASIS-4 (oral semaglutide/Wegovy, 64 weeks). For educational comparison only—these are Tirzepatide cuts diabetes risk by

Assemble Your Injection Device: If you're using a syringe and vial, remove the caps and, using a new needle, draw air into the syringe equal to your dose

If you must shift your day, move it by only one day at a time (Monday to Tuesday, then back to Monday the following week) rather than making large jumps

PlexusDx recommends discussing your specific weight loss target, timeline, and health history with your prescribing provider to make an informed decision

Thus, in a dose-response study (with daily dosing to avoid side effects), semaglutide generated weight losses of up to 14% after 52 weeks [39]

Cell 162, 10661077